A new drug developed at the University of Michigan is showing promise in treating two serious conditions: clogged arteries (atherosclerosis) and severe fatty liver disease. Early results in primates suggest it could help prevent these problems before they start. Read on to discover what makes this treatment different—and why researchers are so hopeful about its future.
